Biomedical Engineering Reference
In-Depth Information
10. Paul, S. (1995). The pathophysiologic process of ventricular
remodeling: from infarct to failure,
, pp. 7-21.
11. Frangogiannis, N.G., Shimoni, S., Chang, S.M., Ren, G., Dewald, O.,
Gersch, C., Shan, K., Aggeli, C., Reardon, M., Letsou, G.V., Espada, R.,
Ramchandani, M., Entman, M.L., Zoghbi, W.A. (2002). Active interstitial
remodeling: an important process in the hibernating human
myocardium,
Crit. Care. Nurs. Q
,
18
, pp. 1468-1474.
12. Kostin, S., Pool, L., Elsässer, A., Hein, S., Drexler, H.C., Arnon, E.,
Hayakawa, Y., Zimmermann, R., Bauer, E., Klövekorn, W.P., Schaper, J.
(2003). Myocytes die by multiple mechanisms in failing human hearts,
Circ. Res
J. Am. Coll. Cardiol.
,
39
, pp. 715-724.
13. Mohan, S.B., Parker, M., Wehbi, M., Douglass, P. (2002). Idiopathic
dilated cardiomyopathy: a common but mystifying cause of heart
failure,
.,
92
, 481-487.
14. Li, X., Luo, R., Jiang, R., Chen, R., Hua, W. (2012). Human leukocyte
antigen-DQ beta 1 chain (DQB1) gene polymorphisms are associated
with dilated cardiomyopathy: a systematic review and meta-analysis,
Heart Lung
Cleve Clin. J. Med.,
69
, pp. 360-367.
15. Grünig, E., Tasman, J.A., Kücherer, H., Franz, W., Kübler, W., Katus, H.A.
(1998). Frequency and phenotypes of familial dilated cardiomyopathy,
J. Am. Coll. Cardiol.
,
41
, pp. 186-194.
16. Pfeffer, M.A., Braunwald, E., Moyé, L.A., Basta, L., Brown, E.J. Jr., Cuddy,
T.E., Davis, B.R., Geltman, E.M., Goldman, S., Flaker, G.C., Klein, M., Lamas,
G.A., Packer, M., Rouleau, J., Rouleau, J.L., Rutherford, J., Wertheimer, J.H.,
Hawkins, M. (1992). Effect of captopril on mortality and morbidity in
patients with left ventricular dysfunction after myocardial infarction,
N. Engl. J. Med.,
327
,
31
, pp. 669-677.
17. CIBIS-II Investigators and Committees. (1999). The cardiac
insufficiency bisoprolol study II (CIBIS-II): a randomized trial,
Lancet,
, pp. 9-13.
18. Packer, M., Coats, A.J., Fowler, M.B., Katus, H.A., Krum, H., Mohacsi, P.,
Rouleau, J.L., Tendera, M., Castaigne, A., Roecker, E.B., Schultz, M.K.,
DeMets, D.L. (2001). Effect of carvedilol on survival in severe chronic
heart failure,
353
, pp. 1651-1658.
19. Cleland, J.G., Pennell, D.J., Ray, S.G., Coats, A.J., Macfarlane, P.W., Murray,
G.D., Mule, J.D., Vered, Z., Lahiri, A. (2003). Myocardial viability as a
determinant of the ejection fraction response to carvedilol in patients
with heart failure (CHRISTMAS trial): randomized controlled trial,
Lancet,
362
N. Engl. J. Med.,
344
, pp. 14-21.
